These are articles and external links to the websites of organisations that are carrying out research and other medical work into different aspects of Wolfram Syndrome, that you might be interested in.
These are articles and external links to the websites of organisations that are carrying out research and other medical work into different aspects of Wolfram Syndrome, that you might be interested in.
European Commission grants orphan drug status for Amylyx’s Wolfram treatmentAmylyx reported positive interim analysis results from its Phase II HELIOS clinical trial of AMX0035 – August 2024
Targeting shared molecular etiologies to accelerate drug development for rare diseases – July 2023
GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models – March 2023
Although these third party organisations are shown on our website as they may provide helpful information, they are not endorsed by WSUK
Designed by Innovative Igloo